Albuquerque, NM, United States of America

Charles Jeffrey Brinker

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 2.6

ph-index = 10

Forward Citations = 460(Granted Patents)


Company Filing History:


Years Active: 1992-2023

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: **Charles Jeffrey Brinker: An Innovator in Cancer Treatment**

Introduction

Charles Jeffrey Brinker is a notable inventor based in Albuquerque, NM. With a remarkable total of 16 patents to his name, he has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His innovative work focuses on developing advanced therapeutic techniques that address critical health challenges.

Latest Patents

Brinker’s latest patents showcase groundbreaking advancements. One notable patent is titled "Osteotropic nanoparticles for prevention or treatment of bone metastases." This innovative work highlights the use of protocells or nanoparticles, often coated with a lipid bilayer, aimed at targeting bone tissue. These nanoparticles are designed for delivering bioactive agents beneficial in treating and diagnosing bone cancer, especially in metastases resulting from other cancers such as prostate, breast, lung, and ovarian cancers. Another pivotal patent involves "Active targeting of cells by monosized protocells," where he introduced mesoporous silica nanoparticles (MSNPs). This patent emphasizes the specificity of cell binding, enabling targeted delivery of therapeutic agents. These advanced delivery systems are anticipated to improve the efficacy of cancer treatments.

Career Highlights

Brinker's career includes significant roles at reputable institutions, including the University of New Mexico and STC.UNM. His engagement in these organizations has allowed him to push the boundaries of research and development in nanomedicine.

Collaborations

Throughout his career, Brinker has collaborated with esteemed colleagues such as Hongyou Fan and David Jerrel Kissel. These partnerships have fostered a collaborative environment conducive to groundbreaking research and innovation in cancer therapies.

Conclusion

Charles Jeffrey Brinker exemplifies the spirit of innovation in medical research, particularly through his impactful patents focusing on cancer treatment. His dedication to developing effective solutions for complex health issues continues to inspire advancements in the field. With ongoing research and collaboration, Brinker undoubtedly plays a crucial role in shaping the future of cancer therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…